Skip to content
lifestyle.friendhood.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Elutia Inc.
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
August 18, 2026
Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market
August 17, 2026
Elutia Secures $15 Million Loan Financing from Avenue Capital Group to Fund NXT-41x Launch in $1.5 Billion Plastic and Reconstructive Surgery Market
August 17, 2026
Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results
August 13, 2026
Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
July 31, 2026
Elutia Signs Definitive Agreement to Sell SimpliDerm® in Transaction Valued at up to $11 Million, Strengthening Balance Sheet Ahead of NXT-41x Launch
July 16, 2026
Elutia to Present at Planet MicroCap Showcase 2026 on June 17th
June 11, 2026
Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
April 30, 2026
Elutia to Present at Sidoti’s Small-Cap Virtual Investor Conference March 18-19
March 17, 2026
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
March 13, 2026
1
2
Next Page
→